Eicosanoids and venous thromboembolism.
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism / Q000502:physiology; D001241:Aspirin / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004285:Dogs; D011464:Epoprostenol / Q000096:biosynthesis; D006487:Hemostasis; D006801:Humans; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation; D011655:Pulmonary Embolism / Q000503:physiopathology; D013923:Thromboembolism / Q000097:blood / Q000378:metabolism; D013924:Thrombophlebitis / Q000517:prevention & control; D013928:Thromboxane A2 / Q000096:biosynthesis
D001095:Arachidonic Acids; D013928:Thromboxane A2; D004176:Dipyridamole; D011464:Epoprostenol; D001241:Aspirin